No studies have singularly investigated the relationship between pyruvate availability, pyruvate dehydrogenase complex (PDC) activation, and anaplerosis in skeletal muscle. This is surprising given the functional importance attributed to these processes in normal and disease states. We investigated the effects of changing pyruvate availability with dichloroacetate (DCA), epinephrine, and pyruvate infusions on PDC activation and accumulation of acetyl groups and tricarboxylic acid (TCA) cycle intermediates (TCAI) in human muscle. DCA increased resting PDC activity sixfold (P < 0.05) but decreased the muscle TCAI pool (mmol/kg dry muscle) from 1.174 ± 0.042 to 0.747 ± 0.055 (P < 0.05). This was probably a result of pyruvate being diverted to acetyl-CoA and acetylcarnitine after near-maximal activation of PDC by DCA. Conversely, neither epinephrine nor pyruvate activated PDC. However, both increased the TCAI pool (1.128 ± 0.076 to 1.614 ± 0.188, P < 0.05 and 1.098 ± 0.059 to 1.385 ± 0.114, P < 0.05, respectively) by providing a readily available pool of pyruvate for anaplerosis. These data support the hypothesis that TCAI pool expansion is principally a reflection of increased muscle pyruvate availability and, together with our previous work (J. A. Timmons, S. M. Poucher, D. Constantin-Teodosiu, V. Worrall, I. A. Macdonald, and P. L. Greenhaff. J. Clin. Invest. 97: 879-883, 1996), indicate that TCA cycle expansion may be of little functional significance to TCA cycle flux. It would appear therefore that the primary effect of DCA on oxidative ATP provision is to provide a readily available pool of acetyl groups to the TCA cycle at the onset of exercise rather than increasing TCA cycle flux by expanding the TCAI pool.

dichloroacetate; epinephrine; pyruvate dehydrogenase complex; acetylcarnitine

This article has been cited by other articles:

				W. J. Ellingson, D. G. Chesser, and W. W. Winder Effects of 3-phosphoglycerate and other metabolites on the activation of AMP-activated protein kinase by LKB1-STRAD-MO25 Am J Physiol Endocrinol Metab, February 1, 2007; 292(2): E400 - E407. [Abstract] [Full Text] [PDF]

				K. D. Dawson, K. R. Howarth, M. A. Tarnopolsky, N. D. Wong, and M. J. Gibala Short-term training attenuates muscle TCA cycle expansion during exercise in women J Appl Physiol, September 1, 2003; 95(3): 999 - 1004. [Abstract] [Full Text] [PDF]

				I. Savasi, M. K. Evans, G. J. F. Heigenhauser, and L. L. Spriet Skeletal muscle metabolism is unaffected by DCA infusion and hyperoxia after onset of intense aerobic exercise Am J Physiol Endocrinol Metab, July 1, 2002; 283(1): E108 - E115. [Abstract] [Full Text] [PDF]

				M. Bruce, D. Constantin-Teodosiu, P. L. Greenhaff, L. H. Boobis, C. Williams, and J. L. Bowtell Glutamine supplementation promotes anaplerosis but not oxidative energy delivery in human skeletal muscle Am J Physiol Endocrinol Metab, April 1, 2001; 280(4): E669 - E675. [Abstract] [Full Text] [PDF]

				M. A. Morrison, L. L. Spriet, and D. J. Dyck Pyruvate ingestion for 7 days does not improve aerobic performance in well-trained individuals J Appl Physiol, August 1, 2000; 89(2): 549 - 556. [Abstract] [Full Text] [PDF]

				M. J. Gibala, M. Lozej, M. A. Tarnopolsky, C. McLean, and T. E. Graham Low glycogen and branched-chain amino acid ingestion do not impair anaplerosis during exercise in humans J Appl Physiol, November 1, 1999; 87(5): 1662 - 1667. [Abstract] [Full Text] [PDF]